PHIA N Stock Overview
Operates as a health technology company in North America, the Greater China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €315.13 |
| 52 Week High | €319.63 |
| 52 Week Low | €248.14 |
| Beta | 0.85 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -21.64% |
| 33 Year Change | -68.75% |
| 5 Year Change | n/a |
| Change since IPO | -59.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHIA N | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -21.6% | 0% | 0% |
Return vs Industry: PHIA N underperformed the MX Medical Equipment industry which returned -2.1% over the past year.
Return vs Market: PHIA N underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
| PHIA N volatility | |
|---|---|
| PHIA N Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: PHIA N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHIA N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 77,233 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
Koninklijke Philips N.V. Fundamentals Summary
| PHIA N fundamental statistics | |
|---|---|
| Market cap | Mex$325.64b |
| Earnings (TTM) | -Mex$39.72b |
| Revenue (TTM) | Mex$336.72b |
1.0x
P/S Ratio-8.3x
P/E RatioIs PHIA N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHIA N income statement (TTM) | |
|---|---|
| Revenue | €18.08b |
| Cost of Revenue | €10.64b |
| Gross Profit | €7.44b |
| Other Expenses | €9.57b |
| Earnings | -€2.13b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 24, 2023
| Earnings per share (EPS) | -2.32 |
| Gross Margin | 41.15% |
| Net Profit Margin | -11.79% |
| Debt/Equity Ratio | 61.7% |
How did PHIA N perform over the long term?
See historical performance and comparison